Biography
Dr Locke's research primarily involves epigenetics and genomics, with a particular focus on DNA methylation. Currently, Dr Locke is undertaking research to exploit DNA methylation patterns for the detection and diagnosis of brain injury.
In his previous role, Dr Locke researched the impact of epigenomic dysregulation on the initiation of carcinogenesis (i.e. the formation of cancer). During this time, Dr Locke was also part of a large multi-center team working to develop biomarkers for the diagnosis and prognosis of triple negative breast cancer.
Fields of Research
Current Roles
-
Research Scientist
Diagnostics Development Team Leader
Academic Qualifications
-
2013
PhD
University of New South Wales -
2006
BSc (Honours)
The University of New England -
2005
BSc Biochemistry & Genetics (Double Major)
The University of New England
Professional Experiences
-
April 2013-April 2017
Postdoctoral Scientist
The Garvan Institute of Medical Research
Community and Corporate Citizenship
-
25/07/2022-24/07/2023
Westmead Deputy Site Leader
ORCID 0000-0002-9281-0363